Non-ownership Filings
| Underwritten Open Offer | Oct. 28, 2025 |
| Change of Auditor | Oct. 10, 2025 |
| US FDA ODD Application Submitted for NXP002 | Aug. 11, 2025 |
| Total Voting Rights | May. 30, 2025 |
| Confirmation of European ODD for NXP002 | May. 29, 2025 |
| Publication of a Prospectus | May. 23, 2025 |
| Prospectus | May. 23, 2025 |
Ownership Update Filings
| Director/PDMR Dealings | Nov. 05, 2024 |
| Holding(s) in Company | Jul. 26, 2023 |
| Holding(s) in Company | Apr. 26, 2023 |
| Holding(s) in Company | Jan. 03, 2023 |
| Holding(s) in Company | Nov. 16, 2022 |
| Holding(s) in Company | Aug. 19, 2022 |
| Holding(s) in Company | Jun. 20, 2022 |